HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced cloning efficiency of murine rhabdomyosarcoma cells after chlorozotocin treatment: relationship with enhanced lung metastasis.

Abstract
The effect of chlorozotocin [(CZT) CAS: 54749-90-5; 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-gluco-pyranose] was studied on a series of tumor cells, cultured or extracted fresh primary or transplanted tumors, by means of clonogenic assay. The ability of most rat rhabdomyosarcoma cells to form colonies in soft agar was enhanced when exposed to the water-soluble nitrosourea chloride CZT. The tumor cells tested were derived from a) several primary tumors induced in WAG rats by colloidal nickel, then cultured and exposed to CZT early during in vitro passage; b) the 9-4 tumor, also Ni-induced but maintained in long-term culture; and c) the Ni-induced 9-4/0 tumor, maintained by transplantation in syngeneic rats. No inhibition of colony formation was observed in any of the cell lines even at high concentrations of CZT. Adriamycin, chosen as a control treatment, strongly inhibited the cloning efficiency (CE) of the tumor cells. In vivo, the weekly injection of 10 mg CZT/kg body weight into syngeneic rats bearing transplanted tumors led to an enhancement of lung metastasis formation. The CZT enhancement of CE of tumor cells and its relationship to increased in vivo tumor metastasis is discussed.
AuthorsC Pauwels, J L Rebischung, C Jasmin, M F Poupon
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 74 Issue 4 Pg. 817-20 (Apr 1985) ISSN: 0027-8874 [Print] United States
PMID3157818 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • chlorozotocin
  • Streptozocin
  • Doxorubicin
Topics
  • Animals
  • Cell Division (drug effects)
  • Clone Cells
  • Colony-Forming Units Assay
  • Dose-Response Relationship, Drug
  • Doxorubicin (pharmacology)
  • Lung Neoplasms (secondary)
  • Male
  • Rats
  • Rhabdomyosarcoma (pathology)
  • Streptozocin (analogs & derivatives, pharmacology)
  • Tumor Stem Cell Assay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: